Oncothyreon Inc (ONTY.OQ)

ONTY.OQ on NASDAQ Stock Exchange Global Select Market

3.01USD
22 May 2015
Change (% chg)

$0.50 (+19.92%)
Prev Close
$2.51
Open
$3.12
Day's High
$3.44
Day's Low
$2.80
Volume
6,499,847
Avg. Vol
473,638
52-wk High
$3.60
52-wk Low
$1.41

ONTY.OQ

Chart for ONTY.OQ

About

Oncothyreon Inc. (Oncothyreon) is a clinical-stage biopharmaceutical company focused primarily on the development of therapeutic products for the treatment of cancer. The Company’s cancer vaccines are designed to stimulate the immune system to attack cancer cells, while its small molecule compounds are designed to inhibit the... (more)

Overall

Beta: 1.09
Market Cap(Mil.): $307.93
Shares Outstanding(Mil.): 102.30
Dividend: --
Yield (%): --

Financials

  ONTY.OQ Industry Sector
P/E (TTM): -- 309.95 39.17
EPS (TTM): -0.55 -- --
ROI: -53.61 -5.54 15.58
ROE: -57.15 -6.56 16.57
Search Stocks

Competitors

  Price Chg
Roche Holding Ltd. (ROG.VX) CHF277.90 -1.30
GlaxoSmithKline plc (GSK.L) 1,464.50p +14.00
Eli Lilly and Co (LLY.N) $74.30 +0.03
Transgene SA (TRNG.PA) €4.97 +0.05
Puma Biotechnology Inc (PBYI.N) $190.91 -0.79

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks